Innocrin Pharmaceuticals, Inc.
Durham, United States (US) · Health and Medical
Do your work at Innocrin Pharmaceuticals, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Innocrin Pharmaceuticals is a US-based, clinical-stage pharmaceutical company specializing in the development of innovative oral CYP17 lyase inhibitors.We are focused on addressing the critical needs of patients with castration-resistant prostate cancer (CRPC), a challenging and often aggressive form of the disease.
Overview
We are focused on addressing the critical needs of patients with castration-resistant prostate cancer (CRPC), a challenging and often aggressive form of the disease. Our lead product candidate targets this specific patient population, offering a potentially ‘best-in-class’ treatment option.
Innocrin’s research and development efforts extend to exploring the potential application of these inhibitors in other hormonally-driven conditions, including breast cancer, endometriosis, and congenital adrenal hyperlplasia. We are dedicated to advancing precision medicine through targeted therapies.
Founded in 2014, Innocrin Pharmaceuticals is committed to bringing transformative medicines to patients worldwide.
Contact Details
Durham, United States (US)
Founded
2014
Company Type
Public Limited Company
Employees
2-10
Categories
Companies teams usually look at after Innocrin Pharmaceuticals, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.